zm 241385 has been researched along with tubocurarine in 1 studies
Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (tubocurarine) | Trials (tubocurarine) | Recent Studies (post-2010) (tubocurarine) |
---|---|---|---|---|---|
401 | 3 | 124 | 4,661 | 149 | 52 |
Protein | Taxonomy | zm 241385 (IC50) | tubocurarine (IC50) |
---|---|---|---|
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 9.6 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 9.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alves-Do-Prado, W; Bornia, EC; Correia-de-Sá, P | 1 |
1 other study(ies) available for zm 241385 and tubocurarine
Article | Year |
---|---|
Presynaptic facilitatory adenosine A2A receptors mediate fade induced by neuromuscular relaxants that exhibit anticholinesterase activity.
Topics: Acetylcholine; Animals; Atracurium; Cholinesterase Inhibitors; Diaphragm; Electric Stimulation; Hexamethonium; Male; Muscle Contraction; Neuromuscular Agents; Neuromuscular Junction; Pancuronium; Phrenic Nerve; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptor, Muscarinic M2; Receptors, Nicotinic; Receptors, Presynaptic; Synaptic Transmission; Triazines; Triazoles; Tubocurarine; Vecuronium Bromide | 2011 |